aluates Reports

$ 0.0

Automative

Global Dengue Vaccines Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Published Date: June 2025

Report Code: QYRE-Auto-25Q8996

Global Dengue Vaccines Market Size Status and Forecast 2022

BUY CHAPTERS

Global Dengue Vaccines Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-25Q8996

Report

June 2025

Pages:109

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Sanofi

Takeda

Dengue Vaccines Market Size

In 2024, the global market size of Dengue Vaccines was estimated to be worth US$ 524 million and is forecast to reach approximately US$ 1317 million by 2031 with a CAGR of 14.3% during the forecast period 2025-2031.

Dengue Vaccines Market

Dengue vaccine is a vaccine used to prevent dengue fever in humans. As of 2019, one version is commercially available, known as CYD-TDV, and sold under the brand name Dengvaxia. The vaccine is only recommended in those who have previously had dengue fever or populations in which most people have been previously infected. The value of the vaccine is limited by the fact that it may worsen outcomes in those who have not previously been infected. It is given as three injections over a year.

The only one version which is commercially available now, known as Dengvaxia and produced by Sanofi, don't has enough efficacy. While there are several vaccines are on trial now. TAK-003, developed by Takeda is one stride closer to reaching the sizable market waiting for dengue vaccines as it reports positive top-line results from a massive Phase III trial.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Dengue Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dengue Vaccines.

The Dengue Vaccines market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Dengue Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Dengue Vaccines companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Market Segmentation

Scope of Dengue Vaccines Market Report

Report Metric	Details
Report Name	Dengue Vaccines Market
CAGR	14.3%
Segment by Type	Dengvaxia TAK-003 Others
Segment by Application	Public Sector Private Sector
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Sanofi, Takeda
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Dengue Vaccines in global and regional level.
Chapter 3: Detailed analysis of Dengue Vaccines company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Dengue Vaccines revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion

FAQ for this report

Who are the main players in the Dengue Vaccines Market report?

Ans: The main players in the Dengue Vaccines Market are Sanofi, Takeda

What are the Application segmentation covered in the Dengue Vaccines Market report?

Ans: The Applications covered in the Dengue Vaccines Market report are Public Sector, Private Sector

What are the Type segmentation covered in the Dengue Vaccines Market report?

Ans: The Types covered in the Dengue Vaccines Market report are Dengvaxia, TAK-003, Others

1 Study Coverage

1.1 Dengue Vaccines Product Introduction

1.2 Market by Type

1.2.1 Global Dengue Vaccines Market Size Growth Rate by Type (2020 VS 2024 VS 2031)

1.2.2 Dengvaxia

1.2.3 TAK-003

1.2.4 Others

1.3 Market by Application

1.3.1 Global Dengue Vaccines Market Size Growth Rate by Application (2020 VS 2024 VS 2031)

1.3.2 Public Sector

1.3.3 Private Sector

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Dengue Vaccines Market Size Estimates and Forecasts

2.2 Dengue Vaccines Market Size by Region: 2024 Versus 2031

2.2.1 Global Dengue Vaccines Revenue by Region: 2020-2025

2.2.2 Global Dengue Vaccines Revenue Forecast by Region (2026-2031)

2.2.3 Global Dengue Vaccines Revenue Market Share by Region (2020-2031)

3 Market Segments

3.1 Breakdown Data by Type

3.1.1 Global Dengue Vaccines Revenue by Type (2020-2031)

3.1.2 Global Dengue Vaccines Revenue Market Share by Type (2020-2031)

3.2 Breakdown Data by Application

3.2.1 Global Dengue Vaccines Revenue by Application (2020-2031)

3.2.2 Global Dengue Vaccines Revenue Market Share by Application (2020-2031)

3.3 by Type and by Application Crossing Analysis

3.3.1 Dengvaxia of Dengue Vaccines Revenue Market Share by Application

3.3.2 TAK-003 of Dengue Vaccines Revenue Market Share by Application

3.3.3 Others of Dengue Vaccines Revenue Market Share by Application

4 Global Dengue Vaccines by Company

4.1 Global Dengue Vaccines Revenue by Company (2020-2025)

4.2 Global Dengue Vaccines Revenue Share by Company (2020-2025)

4.3 Competitive Landscape

4.3.1 Key Dengue Vaccines Companies around the World: Ranking by Revenue

4.3.2 Global Dengue Vaccines Market Concentration Ratio (CR5 and HHI) & (2020-2025)

4.3.3 Global Dengue Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

4.4 Global Dengue Vaccines Companies Headquarters & Product Type

4.4.1 Global Dengue Vaccines Companies Headquarters

4.4.2 Date of International Companies Enter into Dengue Vaccines Market

4.4.3 Global Dengue Vaccines Companies Product & Service

4.4.4 Dengvaxia Revenue Market Share of Dengue Vaccines by Company

4.5 Global Dengue Vaccines Mergers & Acquisitions, Expansion Plans

5 Company Profiles

5.1 Sanofi

5.1.1 Sanofi Corporation Information

5.1.2 Sanofi Description, Business Overview

5.1.3 Sanofi Dengue Vaccines Products Offered

5.1.4 Sanofi Dengue Vaccines Revenue and Gross Margin (2020-2025)

5.1.5 Sanofi Dengue Vaccines Revenue by Product in 2024

5.1.6 Sanofi Dengue Vaccines Revenue by Application in 2024

5.1.7 Sanofi Dengue Vaccines Revenue by Geographic Area in 2024

5.1.8 Sanofi Recent Developments

5.2 Takeda

5.2.1 Takeda Corporation Information

5.2.2 Takeda Description, Business Overview

5.2.3 Takeda Dengue Vaccines Products Offered

5.2.4 Takeda Dengue Vaccines Revenue and Gross Margin (2020-2025)

5.2.5 Takeda Dengue Vaccines Revenue by Product in 2024

5.2.6 Takeda Dengue Vaccines Revenue by Application in 2024

5.2.7 Takeda Dengue Vaccines Revenue by Geographic Area in 2024

5.2.8 Takeda Recent Developments

6 North America

6.1 North America Dengue Vaccines Market Size YoY Growth 2020-2031

6.2 North America Dengue Vaccines Market Facts & Figures by Country (2020-2031)

6.3 North America Dengue Vaccines Revenue by Type (2020-2025)

6.4 North America Dengue Vaccines Revenue by Application (2020-2025)

7 Asia-Pacific

7.1 Asia-Pacific Dengue Vaccines Market Size YoY Growth 2020-2031

7.2 Asia-Pacific Dengue Vaccines Market Facts & Figures by Region (2020-2031)

7.3 Asia-Pacific Dengue Vaccines Revenue by Type (2020-2025)

7.4 Asia-Pacific Dengue Vaccines Revenue by Application (2020-2025)

8 Europe

8.1 Europe Dengue Vaccines Market Size YoY Growth 2020-2031

8.2 Europe Dengue Vaccines Market Facts & Figures by Country (2020-2031)

8.3 Europe Dengue Vaccines Revenue by Type (2020-2025)

8.4 Europe Dengue Vaccines Revenue by Application (2020-2025)

9 Latin America

9.1 Latin America Dengue Vaccines Market Size YoY Growth 2020-2031

9.2 Latin America Dengue Vaccines Market Facts & Figures by Country (2020-2031)

9.3 Latin America Dengue Vaccines Revenue by Type (2020-2025)

9.4 Latin America Dengue Vaccines Revenue by Application (2020-2025)

10 Middle East and Africa

10.1 Latin America Dengue Vaccines Market Size YoY Growth 2020-2031

10.2 Middle East and Africa Dengue Vaccines Market Facts & Figures by Country (2020-2031)

10.3 Middle East and Africa Dengue Vaccines Revenue by Type (2020-2025)

10.4 Middle East and Africa Dengue Vaccines Revenue by Application (2020-2025)

11 Supply Chain and Sales Channel analysis

11.1 Dengue Vaccines Supply Chain Analysis

11.2 Dengue Vaccines Key Raw Materials and Upstream Suppliers

11.3 Dengue Vaccines Clients Analysis

11.4 Dengue Vaccines Sales Channel and Sales Model Analysis

11.4.1 Dengue Vaccines Distribution Channel Analysis: Indirect Sales VS Direct Sales

11.4.2 Dengue Vaccines Distribution Channel Analysis: Online Sales VS Offline Sales

11.4.3 Dengue Vaccines Distributors

12 Dengue Vaccines Market Dynamics

12.1 Dengue Vaccines Industry Trends

12.2 Dengue Vaccines Market Drivers

12.3 Dengue Vaccines Market Challenges

12.4 Dengue Vaccines Market Restraints

13 Research Findings and Conclusion

14 Appendix

14.1 Research Methodology

14.1.1 Methodology/Research Approach

14.1.1.1 Research Programs/Design

14.1.1.2 Market Size Estimation

14.1.1.3 Market Breakdown and Data Triangulation

14.1.2 Data Source

14.1.2.1 Secondary Sources

14.1.2.2 Primary Sources

14.2 Author Details

14.3 Disclaimer

FEATURED COMPANIES

Sanofi

Takeda

List of Tables

Table 1. Global Dengue Vaccines Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Global Dengue Vaccines Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 3. Global Dengue Vaccines Market Size by Region (US$ Million): 2024 VS 2031

Table 4. Global Dengue Vaccines Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global Dengue Vaccines Revenue Forecast by Region (2026-2031) & (US$ Million)

Table 6. Global Dengue Vaccines Revenue by Type (2020-2025) & (US$ Million)

Table 7. Global Dengue Vaccines Revenue Forecast by Type (2026-2031) & (US$ Million)

Table 8. Global Dengue Vaccines Revenue by Application (2020-2025) & (US$ Million)

Table 9. Global Dengue Vaccines Revenue Forecast by Application (2026-2031) & (US$ Million)

Table 10. Dengue Vaccines Revenue by Company (2020-2025) & (US$ Million)

Table 11. Dengue Vaccines Revenue Share by Company (2020-2025)

Table 12. Ranking of Global Top Dengue Vaccines Players by Revenue (US$ Million) in 2024

Table 13. Global Dengue Vaccines Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)

Table 14. Global Dengue Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dengue Vaccines as of 2024)

Table 15. Global Dengue Vaccines Companies Headquarters

Table 16. Date of International Companies Enter into Dengue Vaccines Market

Table 17. Global Dengue Vaccines Companies Product & Service

Table 18. Global Dengue Vaccines Mergers & Acquisitions, Expansion Plans

Table 19. Sanofi Corporation Information

Table 20. Sanofi Description and Business Overview

Table 21. Sanofi Dengue Vaccines Product

Table 22. Sanofi Dengue Vaccines Revenue (US$ Million) and Gross Margin (2020-2025)

Table 23. Sanofi Revenue Proportion of Dengue Vaccines by Product in 2024

Table 24. Sanofi Revenue Proportion of Dengue Vaccines by Application in 2024

Table 25. Sanofi Revenue Proportion of Dengue Vaccines by Geographic Area in 2024

Table 26. Sanofi Recent Developments

Table 27. Takeda Corporation Information

Table 28. Takeda Description and Business Overview

Table 29. Takeda Dengue Vaccines Product

Table 30. Takeda Dengue Vaccines Revenue (US$ Million) and Gross Margin (2020-2025)

Table 31. Takeda Revenue Proportion of Dengue Vaccines by Product in 2024

Table 32. Takeda Revenue Proportion of Dengue Vaccines by Application in 2024

Table 33. Takeda Revenue Proportion of Dengue Vaccines by Geographic Area in 2024

Table 34. Takeda Recent Developments

Table 35. North America Dengue Vaccines Revenue by Country (2020-2025) & (US$ Million)

Table 36. North America Dengue Vaccines Revenue by Country (2026-2031) & (US$ Million)

Table 37. North America Dengue Vaccines Revenue by Type (2020-2025) & (US$ Million)

Table 38. North America Dengue Vaccines Revenue by Application (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Dengue Vaccines Revenue by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Dengue Vaccines Revenue by Region (2026-2031) & (US$ Million)

Table 41. Asia-Pacific Dengue Vaccines Revenue by Type (2020-2025) & (US$ Million)

Table 42. Asia-Pacific Dengue Vaccines Revenue by Application (2020-2025) & (US$ Million)

Table 43. Europe Dengue Vaccines Revenue by Country (2020-2025) & (US$ Million)

Table 44. Europe Dengue Vaccines Revenue by Country (2026-2031) & (US$ Million)

Table 45. Europe Dengue Vaccines Revenue by Type (2020-2025) & (US$ Million)

Table 46. Europe Dengue Vaccines Revenue by Application (2020-2025) & (US$ Million)

Table 47. Latin America Dengue Vaccines Revenue by Country (2020-2025) & (US$ Million)

Table 48. Latin America Dengue Vaccines Revenue by Country (2026-2031) & (US$ Million)

Table 49. Latin America Dengue Vaccines Revenue by Type (2020-2025) & (US$ Million)

Table 50. Latin America Dengue Vaccines Revenue by Application (2020-2025) & (US$ Million)

Table 51. Middle East and Africa Dengue Vaccines Revenue by Country (2020-2025) & (US$ Million)

Table 52. Middle East and Africa Dengue Vaccines Revenue by Country (2026-2031) & (US$ Million)

Table 53. Middle East and Africa Dengue Vaccines Revenue by Type (2020-2025) & (US$ Million)

Table 54. Middle East and Africa Dengue Vaccines Revenue by Application (2020-2025) & (US$ Million)

Table 55. Dengue Vaccines Key Raw Materials, Industry Status and Trend

Table 56. Dengue Vaccines Key Raw Materials and Upstream Suppliers

Table 57. Dengue Vaccines Clients Status and Trend

Table 58. Dengue Vaccines Typical Clients

Table 59. Dengue Vaccines Distributors

Table 60. Dengue Vaccines Market Trends

Table 61. Dengue Vaccines Market Drivers

Table 62. Dengue Vaccines Market Challenges

Table 63. Dengue Vaccines Market Restraints

Table 64. Research Programs/Design for This Report

Table 65. Key Data Information from Secondary Sources

Table 66. Key Data Information from Primary Sources

List of Figures

Figure 1. Dengue Vaccines Product Picture

Figure 2. Global Dengue Vaccines Market Size by Type (US$ Million): 2020 VS 2024 VS 2031

Figure 3. Global Dengue Vaccines Revenue Market Share by Type in 2024 & 2031

Figure 4. Dengvaxia Product Picture

Figure 5. TAK-003 Product Picture

Figure 6. Others Product Picture

Figure 7. Global Dengue Vaccines Market Size by Application (US$ Million): 2020 VS 2024 VS 2031

Figure 8. Global Dengue Vaccines Revenue Market Share by Application in 2024 & 2031

Figure 9. Public Sector

Figure 10. Private Sector

Figure 11. Dengue Vaccines Report Years Considered

Figure 12. Global Dengue Vaccines Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Dengue Vaccines Market Size (2020-2031) & (US$ Million)

Figure 14. Global Dengue Vaccines Market Size Market Share by Region: 2024 Versus 2031

Figure 15. Global Dengue Vaccines Revenue Market Share by Region (2020-2031)

Figure 16. Global Dengue Vaccines Revenue Market Share Forecast by Type (2020-2031)

Figure 17. Global Dengue Vaccines Revenue Market Share Forecast by Application (2020-2031)

Figure 18. Dengvaxia of Dengue Vaccines Revenue Market Share by Application, 2024 VS 2031

Figure 19. TAK-003 of Dengue Vaccines Revenue Market Share by Application, 2024 VS 2031

Figure 20. Others of Dengue Vaccines Revenue Market Share by Application, 2024 VS 2031

Figure 21. Dengue Vaccines Revenue Share by Company (2024)

Figure 22. Dengue Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 23. Dengvaxia Revenue Proportion by Company in 2024

Figure 24. TAK-003 Revenue Proportion by Company in 2024

Figure 25. Others Revenue Proportion by Company in 2024

Figure 26. North America Dengue Vaccines Revenue 2020-2031 (US$ Million)

Figure 27. North America Dengue Vaccines Revenue Market Share by Type (2020-2025)

Figure 28. North America Dengue Vaccines Revenue Market Share by Application (2020-2025)

Figure 29. Asia-Pacific Dengue Vaccines Revenue 2020-2031 (US$ Million)

Figure 30. Asia-Pacific Dengue Vaccines Revenue Market Share by Region (2020-2031)

Figure 31. Asia-Pacific Dengue Vaccines Revenue Market Share by Type (2020-2025)

Figure 32. Asia-Pacific Dengue Vaccines Revenue Market Share by Application (2020-2025)

Figure 33. Europe Dengue Vaccines Revenue Growth Rate 2020-2031 (US$ Million)

Figure 34. Europe Dengue Vaccines Revenue Market Share by Country (2020-2031)

Figure 35. Europe Dengue Vaccines Revenue Market Share by Type (2020-2025)

Figure 36. Europe Dengue Vaccines Revenue Market Share by Application (2020-2025)

Figure 37. Latin America Dengue Vaccines Revenue Growth Rate 2020-2031 (US$ Million)

Figure 38. Latin America Dengue Vaccines Revenue Market Share by Country (2020-2031)

Figure 39. Latin America Dengue Vaccines Revenue Market Share by Type (2020-2025)

Figure 40. Latin America Dengue Vaccines Revenue Market Share by Application (2020-2025)

Figure 41. Middle East and Africa Dengue Vaccines Revenue Growth Rate 2020-2031 (US$ Million)

Figure 42. Middle East and Africa Dengue Vaccines Revenue Market Share by Country (2020-2031)

Figure 43. Middle East and Africa Dengue Vaccines Revenue Market Share by Type (2020-2025)

Figure 44. Middle East and Africa Dengue Vaccines Revenue Market Share by Application (2020-2025)

Figure 45. Dengue Vaccines Supply Chain (Upstream and Downstream Market)

Figure 46. Global Production Market Share of Dengue Vaccines Raw Materials by Region in 2024

Figure 47. Dengue Vaccines Distribution Channels

Figure 48. Global Dengue Vaccines Percentage 2020-2031: Indirect Sales VS Direct Sales

Figure 49. Global Dengue Vaccines Percentage 2020-2031: Online Sales VS Offline Sales

Figure 50. Bottom-up and Top-down Approaches for This Report

Figure 51. Data Triangulation

Figure 52. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$5900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Human Rabies Vaccine Market Research Report 2024

Malaria Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Dengue Virus Testing Market Research Report 2025

Hepatitis Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Poliovirus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Cervical Cancer Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Coccidiosis Vaccine for Chickens Market Research Report 2024

Global Yellow Fever Vaccination Market Research Report 2025

Global Yellow Fever Vaccines Market Insights Forecast to 2030

Duck Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Dengue Fever Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Dengue Rapid Test Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global DPT Vaccines Market Research Report 2025

Disease Control and Prevention Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Human Rabies Vaccination Market Research Report 2025

Global DPT Vaccination Market Research Report 2025

Global Marek s Disease Vaccine Market Research Report 2024

Global DTaP and Tdap Vaccines Market Insights Forecast to 2030

Chicken Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions